Loss of type I IFN responsiveness impairs natural killer cell antitumor activity in breast cancer
Author:
Funder
Victorian Cancer Agency
Cancer Council Victoria
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Link
https://link.springer.com/content/pdf/10.1007/s00262-021-02857-z.pdf
Reference78 articles.
1. Galon J, Angell H, Bedognetti D, Marincola F (2013) The Continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures. Immunity 39:11–26. https://doi.org/10.1016/j.immuni.2013.07.008
2. Gonzalez H, Hagerling C, Werb Z (2018) Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev 32:1267–1284. https://doi.org/10.1101/gad.314617.118
3. Fridman WH, Pagès F, Sautès-Fridman C, Galon J (2012) The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 12:298–306. https://doi.org/10.1038/nrc3245
4. Boon T, Cerottini J-C, Van den Eynde B et al (1994) Tumor antigens recognized by T Lymphocytes. Annu Rev Immunol 12:337–365. https://doi.org/10.1146/annurev.iy.12.040194.002005
5. Schumacher TN, Schreiber RD (2015) Neoantigens in cancer immunotherapy. Science 80(348):69–74. https://doi.org/10.1126/science.aaa4971
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent advances in mRNA‐based vaccine for cancer therapy; bench to bedside;Cell Biochemistry and Function;2024-02-25
2. INTERFERON-GAMMA: An Overview of its Origin, Mechanisms, and Functions in Health and Disease;Reference Module in Life Sciences;2024
3. Targeting STING in cancer: Challenges and emerging opportunities;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11
4. Remodeled tumor immune microenvironment (TIME) parade via natural killer cells reprogramming in breast cancer;Life Sciences;2023-10
5. Type I interferon and cancer;Immunological Reviews;2023-09-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3